Edition:
United States

Profile: PuriCore PLC (PURI.L)

PURI.L on London Stock Exchange

28.75GBp
7 Dec 2016
Change (% chg)

-1.00p (-3.36%)
Prev Close
29.75p
Open
29.75p
Day's High
--
Day's Low
--
Volume
10,000
Avg. Vol
--
52-wk High
--
52-wk Low
--

PuriCore Plc is a biopharmaceutical company engaged in leveraging its immunomodulatory technology to protect and improve the health of adults and children. The Company is also engaged in development of small molecule therapies in inflammatory diseases with application in dermatology, ophthalmology and rare diseases, and also for applicability across various other diseases. The Company operates through two segments: Supermarket Retail and Health Sciences. It serves the Supermarket Retail sector and Wound Care market with various technologies and formulations based on its hypochlorous acid technology. In Supermarket Retail segment, the products are used by supermarket retailers across the United States and Canada to manage freshness of fruits, vegetables and flower displays. In Health Sciences segment, the Company offers a Wound Care solution for cleansing, debriding and moisturizing chronic and acute wounds, including diabetic ulcers and burns.

Company Address

PuriCore PLC

508 Lapp Rd
MALVERN   PA   19355-1214
P: +1484.3212700
F: +1484.3212725

Company Web Links